FTC Says Endo Bankruptcy Can't Stop DC Circ. Appeal
By Katie Buehler · September 8, 2022, 2:50 PM EDT
The Federal Trade Commission has asked the D.C. Circuit to lift a bankruptcy-related stay in its bid to revive antitrust claims accusing Endo Pharmaceuticals Inc. of entering a "pay-for-delay" agreement with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login